These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21133648)

  • 21. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
    Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
    J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
    Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.
    Schmidt K; Wies E; Neipel F
    J Virol; 2011 May; 85(9):4530-7. PubMed ID: 21345951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus.
    Seo T; Park J; Lim C; Choe J
    Oncogene; 2004 Aug; 23(36):6146-55. PubMed ID: 15208654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.
    Lubyova B; Kellum MJ; Frisancho AJ; Pitha PM
    J Biol Chem; 2004 Feb; 279(9):7643-54. PubMed ID: 14668346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LKB1 suppresses KSHV reactivation and promotes primary effusion lymphoma progression.
    Li G; Li Y; Tang X; Wang L; Yue S; He S; Li T
    J Virol; 2024 Sep; 98(9):e0060424. PubMed ID: 39194241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Tabtieng T; Degterev A; Gaglia MM
    J Virol; 2018 May; 92(10):. PubMed ID: 29514903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
    Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
    PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
    Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1, 25(OH)2 D3 Induces Reactivation and Death of Kaposi's Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells.
    Kumar A; Mohanty S; Das P; Sahu SK; Rajasubramaniam S; Choudhuri T
    Sci Rep; 2017 Sep; 7(1):12438. PubMed ID: 28963501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
    Lee HR; Lee S; Chaudhary PM; Gill P; Jung JU
    Future Microbiol; 2010 Sep; 5(9):1349-65. PubMed ID: 20860481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
    Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
    PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
    Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
    J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction with poly(A)-binding protein.
    Kanno T; Sato Y; Sata T; Katano H
    Virology; 2006 Aug; 352(1):100-9. PubMed ID: 16716377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.